Multimodal Management of Calvarial Osteosarcoma with en Bloc Craniectomy and Adjuvant Imatinib Therapy in a Dog
Abstract
An osteosarcoma (OSA) is a malignant mesenchymal tumor characterized by osteoid production by neoplastic osteoblasts. Particularly, calvarial OSA is an uncommon form of canine OSA. A 10-year-old male Pomeranian dog presented with a palpable calvarial mass. Computed tomography (CT) demonstrated a well-defined osseous mass arising from the left parietal bone without intracranial invasion or regional metastasis. An en bloc craniectomy including the affected calvarial bone was performed, and histopathological examination confirmed the diagnosis of OSA. Based on previous reports suggesting that PDGFR-mediated signaling may represent a potential therapeutic target in canine OSA, oral imatinib was planned to be administered for 1 year as postoperative adjuvant therapy. Seven months after surgery, follow-up CT showed no evidence of local recurrence or systemic metastatic disease. Ten months after surgery, the dog was re-evaluated for continued anticancer therapy, with no evidence of local recurrence on physical examination. This case suggests that satisfactory local tumor control can be achieved following surgical excision despite anatomically limited surgical margins. In addition, it provides clinical information regarding postoperative imatinib administration and CT follow-up for canine calvarial OSA. To the best of the authors' knowledge, this is the first report describing adjuvant imatinib therapy following surgical treatment of canine calvarial OSA. However, further studies…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Irisin Enhances Osteoblast DifferentiationIn Vitro
- Glucocorticoids suppress Wnt16 expression in osteoblasts in vitro and in vivo
- Interaction between Schwann Cells and Osteoblasts In Vitro
- Administration of cinnamaldehyde promotes osteogenesis in ovariectomized rats and differentiation of osteoblast in vitro
- The Effect of the Major Components of Fructus Cnidii on Osteoblasts In Vitro
- Estrogen depletion alters osteogenic differentiation and matrix production by osteoblasts in vitro
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.